Brain 'trick' Offers Treatment Hope For Alzheimer's
Main Category: Alzheimer's / DementiaArticle Date: 03 Jul 2008 - 2:00 PDT
| Patient / Public: | ![]() |
4 (5 votes) |
| Healthcare Prof: | ![]() |
4 (4 votes) |
Scientists in the UK and Canada have made a significant step forward in the search for new drugs to treat Alzheimer's disease.
An ageing population means that neurodegeneration, such as Alzheimer's disease, is one of the major health problems in the developed world. But researchers at the University of York and Simon Fraser University in Burnaby, British Columbia, have designed an enzyme inhibitor which could 'trick' the brain and so help to halt neurodegeneration.
The research is published in the latest issue of Nature Chemical Biology.
One of the causes of neurodegeneration is a modification to the protein 'tau', which helps to maintain the stability of neurones in the brain, causing them to form aggregates termed 'tangles'.
These diseases, or 'tauopathies' are believed to be caused by a form of the protein tau which has been excessively modified with phosphate.
By studying the chemistry and structure of relevant enzymes, the research teams at York, led by Professor Gideon Davies, and Simon Fraser, led by Professor David Vocadlo, have designed an enzyme inhibitor that prevents the phosphorylation of tau in animal models. They have effectively tricked the brain's own enzymes into installing a sugar on to tau in place of the detrimental phosphates.
The enzyme inhibitor, termed a 'thiazoline', developed by Professor Vocadlo and Professor Davies is not yet a drug, but it is a major breakthrough in finding compounds that cross the blood-brain barrier to elicit beneficial effects that prevent the onset of tauopathies.
Professor Davies, of the Department of Chemistry at York, said: "We hope that the work will evolve into new drugs to treat Alzheimer's disease, although that is still many years off. The work highlights the synergy of studying the chemistry of enzymes in living cells."
The York /Simon Fraser collaboration also revealed the first structure of the enzyme responsible for the installation of these protective sugars in a paper in Nature Structural & Molecular Biology earlier this month.
YORK UNIVERSITY
Heslington
York
YO10 5DD
http://www.york.ac.uk
Visit our alzheimer's / dementia section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/113760.php>
APA
http://www.medicalnewstoday.com/releases/113760.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





